Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma.

Zhang, Zhenshan; Wu, Leilei; Li, Juan; Chen, Jiayan; Yu, Qi; Yao, Hui; Xu, Yaping; Liu, Liang

Zhang, Zhenshan; Wu, Leilei; Li, Juan; Chen, Jiayan; Yu, Qi; Yao, Hui; Xu, Yaping; Liu, Liang.

Afiliação

Zhang Z; Department of Radiation Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Wu L; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China.
Li J; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, China.
Chen J; Department of Radiation Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Yu Q; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China.
Yao H; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China.
Xu Y; Department of Radiation Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Liu L; Shanghai Concord Cancer Center, Shanghai, 200240, China.

J Transl Med ; 20(1): 602, 2022 12 15.

Article em En | MEDLINE | ID: mdl-36522647

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Humanos; Carcinoma Hepatocelular/genética; Neoplasias Hepáticas/genética; Biomarcadores; Proliferação de Células/genética

Palavras-chave

Biomarker; LIHC; Prognosis; TCGA; ZBTB9

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google